Results 311 to 320 of about 121,769 (336)

GSK-3: An “Ace” Among Kinases

Cancer Biotherapy and Radiopharmaceuticals
Background: Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase known to participate in the regulation of β-catenin signaling (Wnt signaling). This aids in the establishment of a multicomponent destruction complex that stimulates phosphorylation, leading to the destruction of β-catenin.
openaire   +2 more sources

GSK-3, Jack of All Trades

Science Signaling, 2008
Cross-talk between signaling pathways alters transcriptional regulatory activity of the glucocorticoid nuclear receptor.
openaire   +1 more source

The Saccharomyces cerevisiae GSK-3 beta homologs.

Current drug targets, 2007
Yeast cells carry four homologs of GSK-3beta, RIM11, MCK1, MRK1 and YGK3. The significant homologs are RIM11 and MCK1 that presumably arose from a recent genome duplication followed by a rapid divergence. Accordingly, these homologs phosphorylate specific substrates.
Yona, Kassir, Ifat, Rubin-Bejerano, Yael, Mandel-Gutfreund   +2 more
openaire   +2 more sources

GSK-3 signaling in health

Advances in Biological Regulation, 2017
James A, McCubrey, Lucio, Cocco
openaire   +2 more sources

Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor

Nature Medicine, 2003
Laurent Meijer
exaly  

GSK-3

2012
openaire   +1 more source

GSK-3α regulates production of Alzheimer's disease amyloid-β peptides

Nature, 2003
Christopher J Phiel, Peter S Klein
exaly  

GSK-3

2018
openaire   +1 more source

Cdc42 regulates GSK-3β and adenomatous polyposis coli to control cell polarity

Nature, 2003
sandrine Etienne-Manneville
exaly  

Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition

Nature Cell Biology, 2004
Jiong Deng, Mien-Chie Hung
exaly